The impact of hepatitis B viral load on recurrence after complete necrosis in patients with hepatocellular carcinoma who receive transarterial chemolipiodolization : Implications for Viral Suppression to Reduce the Risk of Cancer Recurrence
Hepatocellular carcinoma (HCC) has a high tendency for recurrence after radical treatment. Apart from tumor and liver function parameters, little is known about the role of hepatitis B virus (HBV) factors in the recurrence of HCC. The objective of this study was to identify the potential relation be...
Gespeichert in:
| Veröffentlicht in: | Cancer 2007-10, Vol.110 (8), p.1760-1767 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1767 |
|---|---|
| container_issue | 8 |
| container_start_page | 1760 |
| container_title | Cancer |
| container_volume | 110 |
| creator | Jang, Jeong Won Choi, Jong Young Bae, Si Hyun Yoon, Seung Kew Woo, Hyun Young Chang, U Im Kim, Chang Wook Nam, Soon Woo Cho, Se Hyun Yang, Jin Mo Lee, Chang Don |
| description | Hepatocellular carcinoma (HCC) has a high tendency for recurrence after radical treatment. Apart from tumor and liver function parameters, little is known about the role of hepatitis B virus (HBV) factors in the recurrence of HCC. The objective of this study was to identify the potential relation between viral load and HCC recurrence in patients undergoing transarterial chemolipiodolization.
This was a cohort study of 62 consecutive patients who had HBV-related HCC and achieved complete necrosis with transarterial chemolipiodolization. Risk factors, including viral load for posttreatment recurrence, were analyzed.
Overall, 32 of 62 patients (51.6%) developed a recurrence during the study period (7.2-37.5 months). Multivariate analysis established Child-Pugh Class B (P = .014), multiple tumors (P = .013), and high viral load (HBV DNA levels >10(5) copies/mL) at complete necrosis (P = .001) as independent risk factors for recurrence. On both univariate and multivariate analyses, high viral load at the time of complete necrosis was identified as the strongest factor for recurrence; moreover, its statistically significant effects still were observed even when conducting the analyses separately for both local recurrence (P = .018) and distant recurrence (P = .009).
Among individuals who underwent transarterial chemolipiodolization, high HBV viral load at complete necrosis was among the most important risk factors for posttreatment recurrence, irrespective of the locational pattern of recurrence. The current findings underscored the need for future work that tests the applicability of antiviral therapy to reduce the risk of HCC recurrence in this setting. |
| doi_str_mv | 10.1002/cncr.22984 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68361896</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>68361896</sourcerecordid><originalsourceid>FETCH-LOGICAL-c189t-779c062af4e41bbede3f97f7b6b7e452d2315bf48dd07530c547657859b0e0153</originalsourceid><addsrcrecordid>eNpFkc1u1TAQhS1ERW8LGx4AzQYWlVJsJ44TdnDFT6VKlUpB7CLHGSuGJE5tp1V56j4Czr0XdWWN_M05Z2YIec3oOaOUv9eT9uec11XxjGwYrWVGWcGfkw2ltMpEkf86Jich_E6l5CJ_QY6ZlLyQtNqQx5sewY6z0hGcgR5nFW20AT7BnfVqgMGpDtwEHvXiPU4aQZmIHrQb5wEjwoTau5Ba7ARrN04xwL2N_V7NaRyGZVCpQ3ltJzcquO_dKoj2DiF6NQXlk6RNdrrH0Q12tq5Lz98kl7w_wEXysnpXBTDOw89duO_LPHsMYYWig2vslpQvppGubfizDrRVKbFPP__TvyRHRg0BXx3eU_Ljy-eb7bfs8urrxfbjZaZZVcdMylrTkitTYMHaFjvMTS2NbMtWYiF4x3MmWlNUXUelyKkWhSyFrETdUqRM5Kfk3V539u52wRCb0YZ1FWpCt4SmrPIyOZUJPNuD6xaDR9PM3o7KPzSMNut9m_W-ze6-CX5zUF3aEbsn9HDQBLw9ACpoNZi0XG3DE1ezvOaC5_8A68i1EQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>68361896</pqid></control><display><type>article</type><title>The impact of hepatitis B viral load on recurrence after complete necrosis in patients with hepatocellular carcinoma who receive transarterial chemolipiodolization : Implications for Viral Suppression to Reduce the Risk of Cancer Recurrence</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Wiley Online Library (Open Access Collection)</source><source>Alma/SFX Local Collection</source><creator>Jang, Jeong Won ; Choi, Jong Young ; Bae, Si Hyun ; Yoon, Seung Kew ; Woo, Hyun Young ; Chang, U Im ; Kim, Chang Wook ; Nam, Soon Woo ; Cho, Se Hyun ; Yang, Jin Mo ; Lee, Chang Don</creator><creatorcontrib>Jang, Jeong Won ; Choi, Jong Young ; Bae, Si Hyun ; Yoon, Seung Kew ; Woo, Hyun Young ; Chang, U Im ; Kim, Chang Wook ; Nam, Soon Woo ; Cho, Se Hyun ; Yang, Jin Mo ; Lee, Chang Don</creatorcontrib><description>Hepatocellular carcinoma (HCC) has a high tendency for recurrence after radical treatment. Apart from tumor and liver function parameters, little is known about the role of hepatitis B virus (HBV) factors in the recurrence of HCC. The objective of this study was to identify the potential relation between viral load and HCC recurrence in patients undergoing transarterial chemolipiodolization.
This was a cohort study of 62 consecutive patients who had HBV-related HCC and achieved complete necrosis with transarterial chemolipiodolization. Risk factors, including viral load for posttreatment recurrence, were analyzed.
Overall, 32 of 62 patients (51.6%) developed a recurrence during the study period (7.2-37.5 months). Multivariate analysis established Child-Pugh Class B (P = .014), multiple tumors (P = .013), and high viral load (HBV DNA levels >10(5) copies/mL) at complete necrosis (P = .001) as independent risk factors for recurrence. On both univariate and multivariate analyses, high viral load at the time of complete necrosis was identified as the strongest factor for recurrence; moreover, its statistically significant effects still were observed even when conducting the analyses separately for both local recurrence (P = .018) and distant recurrence (P = .009).
Among individuals who underwent transarterial chemolipiodolization, high HBV viral load at complete necrosis was among the most important risk factors for posttreatment recurrence, irrespective of the locational pattern of recurrence. The current findings underscored the need for future work that tests the applicability of antiviral therapy to reduce the risk of HCC recurrence in this setting.</description><identifier>ISSN: 0008-543X</identifier><identifier>EISSN: 1097-0142</identifier><identifier>DOI: 10.1002/cncr.22984</identifier><identifier>PMID: 17724708</identifier><identifier>CODEN: CANCAR</identifier><language>eng</language><publisher>New York, NY: Wiley-Liss</publisher><subject>Antineoplastic agents ; Biological and medical sciences ; Carcinoma, Hepatocellular - therapy ; Carcinoma, Hepatocellular - virology ; Chemoembolization, Therapeutic ; Chemotherapy ; Combined Modality Therapy ; DNA, Viral - analysis ; Female ; Hepatic Artery ; Hepatitis B - therapy ; Hepatitis B - virology ; Hepatitis B virus - physiology ; Humans ; Iodized Oil - administration & dosage ; Liver Neoplasms - therapy ; Liver Neoplasms - virology ; Male ; Medical sciences ; Middle Aged ; Necrosis ; Neoplasm Recurrence, Local ; Pharmacology. Drug treatments ; Prognosis ; Risk Factors ; Tumors ; Viral Load</subject><ispartof>Cancer, 2007-10, Vol.110 (8), p.1760-1767</ispartof><rights>2007 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c189t-779c062af4e41bbede3f97f7b6b7e452d2315bf48dd07530c547657859b0e0153</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=19139252$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17724708$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jang, Jeong Won</creatorcontrib><creatorcontrib>Choi, Jong Young</creatorcontrib><creatorcontrib>Bae, Si Hyun</creatorcontrib><creatorcontrib>Yoon, Seung Kew</creatorcontrib><creatorcontrib>Woo, Hyun Young</creatorcontrib><creatorcontrib>Chang, U Im</creatorcontrib><creatorcontrib>Kim, Chang Wook</creatorcontrib><creatorcontrib>Nam, Soon Woo</creatorcontrib><creatorcontrib>Cho, Se Hyun</creatorcontrib><creatorcontrib>Yang, Jin Mo</creatorcontrib><creatorcontrib>Lee, Chang Don</creatorcontrib><title>The impact of hepatitis B viral load on recurrence after complete necrosis in patients with hepatocellular carcinoma who receive transarterial chemolipiodolization : Implications for Viral Suppression to Reduce the Risk of Cancer Recurrence</title><title>Cancer</title><addtitle>Cancer</addtitle><description>Hepatocellular carcinoma (HCC) has a high tendency for recurrence after radical treatment. Apart from tumor and liver function parameters, little is known about the role of hepatitis B virus (HBV) factors in the recurrence of HCC. The objective of this study was to identify the potential relation between viral load and HCC recurrence in patients undergoing transarterial chemolipiodolization.
This was a cohort study of 62 consecutive patients who had HBV-related HCC and achieved complete necrosis with transarterial chemolipiodolization. Risk factors, including viral load for posttreatment recurrence, were analyzed.
Overall, 32 of 62 patients (51.6%) developed a recurrence during the study period (7.2-37.5 months). Multivariate analysis established Child-Pugh Class B (P = .014), multiple tumors (P = .013), and high viral load (HBV DNA levels >10(5) copies/mL) at complete necrosis (P = .001) as independent risk factors for recurrence. On both univariate and multivariate analyses, high viral load at the time of complete necrosis was identified as the strongest factor for recurrence; moreover, its statistically significant effects still were observed even when conducting the analyses separately for both local recurrence (P = .018) and distant recurrence (P = .009).
Among individuals who underwent transarterial chemolipiodolization, high HBV viral load at complete necrosis was among the most important risk factors for posttreatment recurrence, irrespective of the locational pattern of recurrence. The current findings underscored the need for future work that tests the applicability of antiviral therapy to reduce the risk of HCC recurrence in this setting.</description><subject>Antineoplastic agents</subject><subject>Biological and medical sciences</subject><subject>Carcinoma, Hepatocellular - therapy</subject><subject>Carcinoma, Hepatocellular - virology</subject><subject>Chemoembolization, Therapeutic</subject><subject>Chemotherapy</subject><subject>Combined Modality Therapy</subject><subject>DNA, Viral - analysis</subject><subject>Female</subject><subject>Hepatic Artery</subject><subject>Hepatitis B - therapy</subject><subject>Hepatitis B - virology</subject><subject>Hepatitis B virus - physiology</subject><subject>Humans</subject><subject>Iodized Oil - administration & dosage</subject><subject>Liver Neoplasms - therapy</subject><subject>Liver Neoplasms - virology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Necrosis</subject><subject>Neoplasm Recurrence, Local</subject><subject>Pharmacology. Drug treatments</subject><subject>Prognosis</subject><subject>Risk Factors</subject><subject>Tumors</subject><subject>Viral Load</subject><issn>0008-543X</issn><issn>1097-0142</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkc1u1TAQhS1ERW8LGx4AzQYWlVJsJ44TdnDFT6VKlUpB7CLHGSuGJE5tp1V56j4Czr0XdWWN_M05Z2YIec3oOaOUv9eT9uec11XxjGwYrWVGWcGfkw2ltMpEkf86Jich_E6l5CJ_QY6ZlLyQtNqQx5sewY6z0hGcgR5nFW20AT7BnfVqgMGpDtwEHvXiPU4aQZmIHrQb5wEjwoTau5Ba7ARrN04xwL2N_V7NaRyGZVCpQ3ltJzcquO_dKoj2DiF6NQXlk6RNdrrH0Q12tq5Lz98kl7w_wEXysnpXBTDOw89duO_LPHsMYYWig2vslpQvppGubfizDrRVKbFPP__TvyRHRg0BXx3eU_Ljy-eb7bfs8urrxfbjZaZZVcdMylrTkitTYMHaFjvMTS2NbMtWYiF4x3MmWlNUXUelyKkWhSyFrETdUqRM5Kfk3V539u52wRCb0YZ1FWpCt4SmrPIyOZUJPNuD6xaDR9PM3o7KPzSMNut9m_W-ze6-CX5zUF3aEbsn9HDQBLw9ACpoNZi0XG3DE1ezvOaC5_8A68i1EQ</recordid><startdate>20071015</startdate><enddate>20071015</enddate><creator>Jang, Jeong Won</creator><creator>Choi, Jong Young</creator><creator>Bae, Si Hyun</creator><creator>Yoon, Seung Kew</creator><creator>Woo, Hyun Young</creator><creator>Chang, U Im</creator><creator>Kim, Chang Wook</creator><creator>Nam, Soon Woo</creator><creator>Cho, Se Hyun</creator><creator>Yang, Jin Mo</creator><creator>Lee, Chang Don</creator><general>Wiley-Liss</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20071015</creationdate><title>The impact of hepatitis B viral load on recurrence after complete necrosis in patients with hepatocellular carcinoma who receive transarterial chemolipiodolization : Implications for Viral Suppression to Reduce the Risk of Cancer Recurrence</title><author>Jang, Jeong Won ; Choi, Jong Young ; Bae, Si Hyun ; Yoon, Seung Kew ; Woo, Hyun Young ; Chang, U Im ; Kim, Chang Wook ; Nam, Soon Woo ; Cho, Se Hyun ; Yang, Jin Mo ; Lee, Chang Don</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c189t-779c062af4e41bbede3f97f7b6b7e452d2315bf48dd07530c547657859b0e0153</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Antineoplastic agents</topic><topic>Biological and medical sciences</topic><topic>Carcinoma, Hepatocellular - therapy</topic><topic>Carcinoma, Hepatocellular - virology</topic><topic>Chemoembolization, Therapeutic</topic><topic>Chemotherapy</topic><topic>Combined Modality Therapy</topic><topic>DNA, Viral - analysis</topic><topic>Female</topic><topic>Hepatic Artery</topic><topic>Hepatitis B - therapy</topic><topic>Hepatitis B - virology</topic><topic>Hepatitis B virus - physiology</topic><topic>Humans</topic><topic>Iodized Oil - administration & dosage</topic><topic>Liver Neoplasms - therapy</topic><topic>Liver Neoplasms - virology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Necrosis</topic><topic>Neoplasm Recurrence, Local</topic><topic>Pharmacology. Drug treatments</topic><topic>Prognosis</topic><topic>Risk Factors</topic><topic>Tumors</topic><topic>Viral Load</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jang, Jeong Won</creatorcontrib><creatorcontrib>Choi, Jong Young</creatorcontrib><creatorcontrib>Bae, Si Hyun</creatorcontrib><creatorcontrib>Yoon, Seung Kew</creatorcontrib><creatorcontrib>Woo, Hyun Young</creatorcontrib><creatorcontrib>Chang, U Im</creatorcontrib><creatorcontrib>Kim, Chang Wook</creatorcontrib><creatorcontrib>Nam, Soon Woo</creatorcontrib><creatorcontrib>Cho, Se Hyun</creatorcontrib><creatorcontrib>Yang, Jin Mo</creatorcontrib><creatorcontrib>Lee, Chang Don</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jang, Jeong Won</au><au>Choi, Jong Young</au><au>Bae, Si Hyun</au><au>Yoon, Seung Kew</au><au>Woo, Hyun Young</au><au>Chang, U Im</au><au>Kim, Chang Wook</au><au>Nam, Soon Woo</au><au>Cho, Se Hyun</au><au>Yang, Jin Mo</au><au>Lee, Chang Don</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The impact of hepatitis B viral load on recurrence after complete necrosis in patients with hepatocellular carcinoma who receive transarterial chemolipiodolization : Implications for Viral Suppression to Reduce the Risk of Cancer Recurrence</atitle><jtitle>Cancer</jtitle><addtitle>Cancer</addtitle><date>2007-10-15</date><risdate>2007</risdate><volume>110</volume><issue>8</issue><spage>1760</spage><epage>1767</epage><pages>1760-1767</pages><issn>0008-543X</issn><eissn>1097-0142</eissn><coden>CANCAR</coden><abstract>Hepatocellular carcinoma (HCC) has a high tendency for recurrence after radical treatment. Apart from tumor and liver function parameters, little is known about the role of hepatitis B virus (HBV) factors in the recurrence of HCC. The objective of this study was to identify the potential relation between viral load and HCC recurrence in patients undergoing transarterial chemolipiodolization.
This was a cohort study of 62 consecutive patients who had HBV-related HCC and achieved complete necrosis with transarterial chemolipiodolization. Risk factors, including viral load for posttreatment recurrence, were analyzed.
Overall, 32 of 62 patients (51.6%) developed a recurrence during the study period (7.2-37.5 months). Multivariate analysis established Child-Pugh Class B (P = .014), multiple tumors (P = .013), and high viral load (HBV DNA levels >10(5) copies/mL) at complete necrosis (P = .001) as independent risk factors for recurrence. On both univariate and multivariate analyses, high viral load at the time of complete necrosis was identified as the strongest factor for recurrence; moreover, its statistically significant effects still were observed even when conducting the analyses separately for both local recurrence (P = .018) and distant recurrence (P = .009).
Among individuals who underwent transarterial chemolipiodolization, high HBV viral load at complete necrosis was among the most important risk factors for posttreatment recurrence, irrespective of the locational pattern of recurrence. The current findings underscored the need for future work that tests the applicability of antiviral therapy to reduce the risk of HCC recurrence in this setting.</abstract><cop>New York, NY</cop><pub>Wiley-Liss</pub><pmid>17724708</pmid><doi>10.1002/cncr.22984</doi><tpages>8</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0008-543X |
| ispartof | Cancer, 2007-10, Vol.110 (8), p.1760-1767 |
| issn | 0008-543X 1097-0142 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_68361896 |
| source | MEDLINE; Access via Wiley Online Library; EZB-FREE-00999 freely available EZB journals; Wiley Online Library (Open Access Collection); Alma/SFX Local Collection |
| subjects | Antineoplastic agents Biological and medical sciences Carcinoma, Hepatocellular - therapy Carcinoma, Hepatocellular - virology Chemoembolization, Therapeutic Chemotherapy Combined Modality Therapy DNA, Viral - analysis Female Hepatic Artery Hepatitis B - therapy Hepatitis B - virology Hepatitis B virus - physiology Humans Iodized Oil - administration & dosage Liver Neoplasms - therapy Liver Neoplasms - virology Male Medical sciences Middle Aged Necrosis Neoplasm Recurrence, Local Pharmacology. Drug treatments Prognosis Risk Factors Tumors Viral Load |
| title | The impact of hepatitis B viral load on recurrence after complete necrosis in patients with hepatocellular carcinoma who receive transarterial chemolipiodolization : Implications for Viral Suppression to Reduce the Risk of Cancer Recurrence |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-19T17%3A57%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20impact%20of%20hepatitis%20B%20viral%20load%20on%20recurrence%20after%20complete%20necrosis%20in%20patients%20with%20hepatocellular%20carcinoma%20who%20receive%20transarterial%20chemolipiodolization%20:%20Implications%20for%20Viral%20Suppression%20to%20Reduce%20the%20Risk%20of%20Cancer%20Recurrence&rft.jtitle=Cancer&rft.au=Jang,%20Jeong%20Won&rft.date=2007-10-15&rft.volume=110&rft.issue=8&rft.spage=1760&rft.epage=1767&rft.pages=1760-1767&rft.issn=0008-543X&rft.eissn=1097-0142&rft.coden=CANCAR&rft_id=info:doi/10.1002/cncr.22984&rft_dat=%3Cproquest_cross%3E68361896%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=68361896&rft_id=info:pmid/17724708&rfr_iscdi=true |